CLINICAL RESEARCH ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About CLINICAL RESEARCH ApS
CLINICAL RESEARCH ApS (CVR number: 31081653) is a company from ODENSE. The company recorded a gross profit of 887.1 kDKK in 2024. The operating profit was -52 kDKK, while net earnings were -42.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -13.9 %, which can be considered poor and Return on Equity (ROE) was -26.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 33.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. CLINICAL RESEARCH ApS's liquidity measured by quick ratio was 1.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 972.00 | 1 104.00 | 1 525.02 | 1 043.57 | 887.14 |
EBIT | 275.00 | 321.00 | 591.50 | 129.98 | -51.97 |
Net earnings | 223.00 | 247.00 | 458.18 | 100.53 | -42.14 |
Shareholders equity total | 286.00 | 374.00 | 591.57 | 232.10 | 89.96 |
Balance sheet total (assets) | 675.00 | 554.00 | 846.71 | 469.69 | 268.68 |
Net debt | - 568.00 | - 273.00 | - 360.34 | - 234.45 | - 216.47 |
Profitability | |||||
EBIT-% | |||||
ROA | 72.9 % | 52.2 % | 84.5 % | 19.8 % | -13.9 % |
ROE | 127.8 % | 74.8 % | 94.9 % | 24.4 % | -26.2 % |
ROI | 155.8 % | 94.6 % | 120.1 % | 31.6 % | -31.6 % |
Economic value added (EVA) | 221.00 | 263.50 | 456.13 | 88.70 | -42.34 |
Solvency | |||||
Equity ratio | 42.4 % | 67.5 % | 69.9 % | 49.4 % | 33.5 % |
Gearing | 5.1 % | 0.1 % | 0.6 % | 0.4 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.7 | 3.1 | 3.3 | 2.0 | 1.5 |
Current ratio | 1.7 | 3.1 | 3.3 | 2.0 | 1.5 |
Cash and cash equivalents | 568.00 | 292.00 | 360.96 | 235.82 | 216.80 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.